CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-02 | McCourt Marion Director | Grant or award · Stock option (right to buy) | +11,800 | $0.86 | $10K | 11,800 |
| 2018-04-02 | Macdonald Guy Director | Grant or award · Stock option (right to buy) | +19,959 | $0.86 | $17K | 19,959 |
| 2018-03-29 | Angulo Gonzalez David Chief Medical Officer | Purchase | +6,000 | $1.36 | $8K | 101,790 |
| 2018-03-08 | Angulo Gonzalez David Chief Medical Officer | Purchase | +7,000 | $1.39 | $10K | 95,790 |
| 2018-03-08 | HASTINGS DAVID C Director | Purchase | +11,834 | $1.69 | $20K | 31,834 |
| 2018-03-08 | HASTINGS DAVID C Director | Purchase · Common Stock Warrant (right to buy) | +8,875 | 8,875 | ||
| 2018-03-08 | HASTINGS DAVID C Director | Purchase · Common Stock Warrant (right to buy) | +5,325 | 5,325 | ||
| 2018-03-08 | Sukenick Scott General Counsel | Purchase | +2,959 | $1.69 | $5K | 2,959 |
| 2018-03-08 | Sukenick Scott General Counsel | Purchase · Common Stock Warrant (right to buy) | +2,219 | 2,219 | ||
| 2018-03-08 | Sukenick Scott General Counsel | Purchase · Common Stock Warrant (right to buy) | +1,331 | 1,331 | ||
| 2018-03-08 | Taglietti Marco Chief Executive Officer | Purchase | +100,000 | $1.69 | $169K | 404,000 |
| 2018-03-08 | Taglietti Marco Chief Executive Officer | Purchase · Common Stock Warrant (right to buy) | +75,000 | 75,000 | ||
| 2018-03-08 | Taglietti Marco Chief Executive Officer | Purchase · Common Stock Warrant (right to buy) | +45,000 | 45,000 | ||
| 2018-03-08 | Francois Eric Chief Financial Officer | Purchase | +5,917 | $1.69 | $10K | 24,917 |
| 2018-03-08 | Francois Eric Chief Financial Officer | Purchase · Common Stock Warrant (right to buy) | +4,437 | 4,437 | ||
| 2018-03-08 | Francois Eric Chief Financial Officer | Purchase · Common Stock Warrant (right to buy) | +2,662 | 2,662 | ||
| 2018-03-08 | Angulo Gonzalez David Chief Medical Officer | Purchase | +14,790 | $1.69 | $25K | 88,790 |
| 2018-03-08 | Angulo Gonzalez David Chief Medical Officer | Purchase · Common Stock Warrant (right to buy) | +11,092 | 11,092 | ||
| 2018-03-08 | Angulo Gonzalez David Chief Medical Officer | Purchase · Common Stock Warrant (right to buy) | +6,655 | 6,655 | ||
| 2018-02-09 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 |
Page 11 of 15 · 286 trades